{"name":"Ajjai Alva, MD","slug":"ajjai-alva-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQZk5BaEZCbks3TDFiSm9EYzFubUhKT29iYW9DTHZiV04zYU5haFhMR3llMlNFbzdfekk1UGJDbEhVY0R3TmpNcnlha3NrcnlLZjF6bllVblZsMmVDaTJHUm03clM0TkV4UVZsZmJhTVJPWWJra0FSNmgzWUZPNWtUNHF3bENWUHZjUjlNdDBqSHVHSk9YQ0JUckpkS1I2a29pdzZfYlFFT19vMUFJcTFmRk12LUFPX0VLektWMXl3eHJvMjRTbmlxb1NSQy15T3h5b2NTY1BtbXB1YkduS3pV?oc=5","date":"2021-05-25","type":"pipeline","source":"Healio","summary":"Pembrolizumab shows promise in metastatic breast cancer with high tumor mutational burden - Healio","headline":"Pembrolizumab shows promise in metastatic breast cancer with high tumor mutational burden","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5HaTJCd2VpRC1nR2R4Y3k2UDRzUENKdXg3Zkc1Z29WNE1Jd0xRVGZZMTNJaFJ4ckJYU3EzYVQ2eHE1N3J5dDdiX0t4QXJmbndQbV8yamlTUFlKZF9NZW11Zlhxa3lXMEJ6Nm9NazRrM081cFhBSmg4QjFmUQ?oc=5","date":"2020-08-05","type":"trial","source":"Wiley","summary":"A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer - Wiley","headline":"A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant m","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}